ARKG vs IEFA
ARK Genomic Revolution ETF vs iShares Core MSCI EAFE ETF
ARKG$43.17
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: 0.75%Yield: 0.00%
IEFA$96.97
iShares Core MSCI EAFE ETF
Developed-market equities ex-US/Canada.
Expense: 0.07%Yield: 3.40%
Quick take
- • IEFA has the lower expense ratio at 0.07% vs 0.75% for ARKG.
- • IEFA pays a higher dividend yield (3.40%).
Side-by-side metrics
| Metric | ARKG | IEFA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.07% |
Dividend yield Trailing 12-month yield. | 0.00% | 3.40% |
AUM Assets under management — bigger funds are typically more liquid. | $1.73B | $186.54B |
YTD return | 44.53% | 9.41% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.38 | 0.89 |
P/E ratio | — | 18.59 |
Last price | $43.17 | $96.97 |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector breakdown · ARKG
Healthcare100.0%
IEFA top holdings
Top holdings · IEFA
| ASML.AS | ASML Holding NV | 3.03% |
| HSBA.L | HSBC Holdings PLC | 1.29% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 1.15% |
| NOVN.SW | Novartis AG Registered Shares | 1.14% |
| AZN.L | AstraZeneca PLC | 1.12% |
| NESN.SW | Nestle SA | 1.05% |
| SIE.DE | Siemens AG | 0.95% |
| SHEL.L | Shell PLC | 0.87% |
| 8035.T | Tokyo Electron Ltd | 0.84% |
| 8306.T | Mitsubishi UFJ Financial Group Inc | 0.84% |
Sector breakdown · IEFA
Real Estate2.8%
Consumer Cyclical8.1%
Basic Materials6.3%
Consumer Defensive6.5%
Technology12.6%
Communication Services4.3%
Financial Services23.1%
Utilities3.5%
Industrials19.7%
Energy3.3%
Healthcare9.8%
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.7B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 9.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About IEFA
IEFA (iShares Core MSCI EAFE ETF) is Developed-market equities ex-US/Canada. Managed by iShares, the fund carries $186.5B in assets under management, an expense ratio of 0.07%, a dividend yield of 3.40%. Its largest holding is ASML Holding NV (ASML.AS), which represents 3.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.8%.